Assessment and Density Functional Theory of Bioactive Compounds of Curcuma longa L. Root Responsible for Its

Ahmed Hemdan1, Sylvester Nnaemeka Ugariogu1, Bashayer D Althufairi1

  • 1Department of Pharmaceutical Chemistry, College of Pharmacy, Health Science Center, Kuwait University, Jabriya, P.O. Box 24923, Safat 13110, Kuwait.

Insights

This study identified bioactive compounds in Curcuma longa root extract, showing potential for developing new cardiovascular and anticancer drugs. Computational analysis revealed promising therapeutic candidates for these major global health challenges.

Area of Science:

  • Phytochemistry
  • Computational Biology
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) and cancer are leading causes of mortality globally, including in Kuwait.
  • Medicinal plants offer a rich source of bioactive compounds with therapeutic potential.

Purpose of the Study:

  • To identify phytochemicals in Curcuma longa root extract.
  • To evaluate their potential cardioprotective and anticancer activities using computational methods.

Main Methods:

  • Gas chromatography-mass spectrometry (GC-MS) for phytochemical profiling.
  • Molecular docking against cardiovascular and cancer targets (HMG-CoA reductase, PI3K, CDK6, HER2).
  • PASS prediction, SwissADME, and Density Functional Theory (DFT) for activity, pharmacokinetics, and electronic properties.

Main Results:

  • Seventeen compounds identified, with 2-oxo-cyclooctaneacetic acid, curlone, and tumerone as major constituents.
  • Favorable binding affinities observed for several compounds against selected targets.
  • Promising biological activities, drug-likeness, and pharmacokinetic profiles predicted for Curcuma longa compounds.

Conclusions:

  • Bioactive compounds from Curcuma longa show potential as lead candidates for cardioprotective and anticancer drug development.
  • Further in vitro and in vivo experimental validation is necessary to confirm these computational findings.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...